Novel use of plasmapheresis in a patient with heparin-induced thrombocytopenia requiring urgent insertion of a left ventricular assist device under cardiopulmonary bypass.
Voeller
Rochus K
RK
Division of Cardiothoracic Surgery, Washington University School of Medicine, Barnes-Jewish Hospital, St Louis, MO 63110, USA. voellerr@wustl.edu
Melby
Spencer J
SJ
Grizzell
Brett E
BE
Moazami
Nader
N
D000906:Antibodies / Q000097:blood; D000925:Anticoagulants / Q000009:adverse effects* / Q000276:immunology; D002315:Cardiopulmonary Bypass; D006353:Heart-Assist Devices; D006493:Heparin / Q000009:adverse effects* / Q000276:immunology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010956:Plasmapheresis; D010978:Platelet Factor 4 / Q000276:immunology; D012770:Shock, Cardiogenic / Q000503:physiopathology / Q000601:surgery*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology; D013997:Time Factors; D016896:Treatment Outcome
D000906:Antibodies; D000925:Anticoagulants; D010978:Platelet Factor 4; D006493:Heparin